| The international classification of headache disorders, (beta version) Headache Classification Committee of the International Headache Society (IHS) Cephalalgia 33 (9), 629-808, 2013 | 12416 | 2013 |
| OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial HC Diener, DW Dodick, SK Aurora, CC Turkel, RE DeGryse, RB Lipton, ... Cephalalgia 30 (7), 804-814, 2010 | 1104 | 2010 |
| OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial SK Aurora, DW Dodick, CC Turkel, RE DeGryse, SD Silberstein, ... Cephalalgia 30 (7), 793-803, 2010 | 1035 | 2010 |
| Epidemiology of chronic daily headache in the general population J Castillo, P Muñoz, V Guitera, J Pascual Headache: The Journal of Head and Face Pain 39 (3), 190-196, 1999 | 1000 | 1999 |
| Guidelines for controlled trials of drugs in migraine International Headache Society Clinical Trials Subcommittee, ... Cephalalgia 20 (9), 765-786, 2000 | 756 | 2000 |
| Epidemiology of headache in Europe LJ Stovner, JA Zwart, K Hagen, GM Terwindt, J Pascual European journal of neurology 13 (4), 333-345, 2006 | 649 | 2006 |
| The international classification of headache disorders, (beta version) DA Ettlin Cephalalgia 33 (9), 629-808, 2013 | 648 | 2013 |
| Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine E Cernuda-Morollón, D Larrosa, C Ramón, J Vega, P Martínez-Camblor, ... Neurology 81 (14), 1191-1196, 2013 | 509 | 2013 |
| Ergotamine in the acute treatment of migraine: a review and European consensus P Tfelt-Hansen, PR Saxena, C Dahlöf, J Pascual, M Lainez, P Henry, ... Brain 123 (1), 9-18, 2000 | 489 | 2000 |
| Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life R Colas, P Munoz, R Temprano, C Gomez, J Pascual Neurology 62 (8), 1338-1342, 2004 | 411 | 2004 |
| Guidelines for controlled trials of drugs in migraine: A guide for investigators International Headache Society Clinical Trials Subcommittee members:, ... Cephalalgia 32 (1), 6-38, 2012 | 408 | 2012 |
| Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS) LM Bloudek, M Stokes, DC Buse, TK Wilcox, RB Lipton, PJ Goadsby, ... The journal of headache and pain 13, 361-378, 2012 | 385 | 2012 |
| Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults S Silberstein, P Tfelt-Hansen, DW Dodick, V Limmroth, RB Lipton, ... Cephalalgia 28 (5), 484-495, 2008 | 329 | 2008 |
| Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases J Pascual, F Iglesias, A Oterino, A Vazquez-Barquero, J Berciano Neurology 46 (6), 1520-1524, 1996 | 327 | 1996 |
| Quality of life in chronic daily headache: a study in a general population V Guitera, P Muñoz, J Castillo, J Pascual Neurology 58 (7), 1062-1065, 2002 | 232 | 2002 |
| Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. F Gómez-Aranda, F Canadillas, JF Martí-Massó, E Díez-Tejedor, ... Brain: a journal of neurology 120 (7), 1105-1113, 1997 | 217 | 1997 |
| Epidemiology of chronic daily headache J Pascual, R Colás, J Castillo Current pain and headache reports 5, 529-536, 2001 | 213 | 2001 |
| Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients E Quintela, J Castillo, P Muñoz, J Pascual Cephalalgia 26 (9), 1051-1060, 2006 | 209 | 2006 |
| CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine E Cernuda‐Morollón, P Martínez‐Camblor, C Ramón, D Larrosa, ... Headache: The Journal of Head and Face Pain 54 (6), 987-995, 2014 | 197 | 2014 |
| OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine JP Eva Cernuda-Morollón, César Ramón, Pablo Martínez-Camblor, Esther Serrano ... Pain 156 (5), 820-824, 2015 | 189 | 2015 |
